Tag: Food and Drug Administration
A study linking popular weight loss drug to suicide risk again raises long-standing safety questions
Editor’s Note: If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing 988 to connect with a trained counselor, or visit the 988 Lifeline website.
People taking semaglutide, the popular medication for diabetes and weight loss, are more likely to report having thoughts of suicide compared with those taking other drugs, according to a new study of an international drug safety database. But the finding is the latest see-saw of scientific evidence on the risk of depression and suicide tied to the popular medications — and critics say evidence that the drugs cause problems with mood is limited.
A study linking popular weight loss drug to suicide risk again raises long-standing safety questions
Related:
Ian Douglas, London School of Hygiene & Tropical Medicine:
I am an epidemiologist, currently funded by GlaxoSmithKline. I initially studied physiology at BSc and PhD level in Manchester. Since then, I spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutical industry investigating adverse effects of drugs – both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005.
Previously:
Medicare to cover obesity drugs, but not for weight loss
Wegovy, Rybelsus, and Ozempic, are the different brand names for Semaglutide. They have a black box warning for Medullary thyroid cancer.* 🤦🏼♀️
Related:
Everything We Learned From Oprah’s Weight Loss Special
Using Mounjaro may increase your risk of developing thyroid cancer.
Violence Caused by Antidepressants Ignored Once Again by Psychiatrists
In 2015, six psychiatrists from the Department of Psychiatry, University of Oxford, the UK, published the study, “Depression and Violence: A Swedish Population Study” in Lancet Psychiatry.
Violence Caused by Antidepressants Ignored Once Again by Psychiatrists
The FDA Just Quietly Gutted Protections for Human Subjects in Research
Late last year, the U.S. Food and Drug Administration (FDA) quietly introduced a regulation that may be one of the most important shifts in how non-profit and for-profit U.S. institutions, both at home and abroad, conduct future medical and public health research. It represents an erosion of personal medical choice and threatens to undermine the public’s trust in scientific investigations in biomedicine.
The FDA Just Quietly Gutted Protections for Human Subjects in Research
Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs
Latest:
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
6 proven health benefits of magnesium—a critical mineral you’re probably not getting enough of
You may already know that magnesium is one of the top supplements for healthy aging, but its benefits go beyond supporting you in your golden years. “It’s essential for all stages of life,” says Andrea Wong, Ph.D., senior vice president for scientific and regulatory affairs at the Council for Responsible Nutrition (CRN).
6 proven health benefits of magnesium—a critical mineral you’re probably not getting enough of (archived)
Council for Responsible Nutrition is a trade association and lobbying group for the dietary supplement industry…lol.
Related:
Lessons From Legalization: The Problem Isn’t Cannabis, It’s Capitalism
420 FILE – The United States government is likely to end the designation of marijuana as a dangerous narcotic sometime this year, potentially marking one of the biggest federal decisions on the classification of the drug in decades. The U.S. Food and Drug Administration determined that marijuana is less harmful than, say, opioids and other substances, prompting the Biden administration to announce it would “reschedule” cannabis from a Schedule I—which is what the most dangerous drugs are classified as—to a Schedule III drug, commensurate with anabolic steroids and ketamine.
Lessons From Legalization: The Problem Isn’t Cannabis, It’s Capitalism
FYI, I’m not against cannabis for medicinal purposes. Especially since I can’t even get a prescription for any painkillers. I could rant about it, but I won’t.
Everything We Learned From Oprah’s Weight Loss Special
Everything We Learned From Oprah’s Weight Loss Special
Related:
Using Mounjaro may increase your risk of developing thyroid cancer.
FDA Settles Lawsuit over Ivermectin Social Media Posts
FDA Settles Lawsuit over Ivermectin Social Media Posts
The FDA has agreed to delete and never republish several social-media posts suggesting that ivermectin, a drug that some doctors used to treat COVID-19, is for animals and not humans.
While the FDA still does not approve of using ivermectin to treat COVID, it settled Thursday a lawsuit brought by three doctors who sued it, as well as the Department of Health and Human Services and its secretary, Xavier Becerra, and FDA secretary Robert Califf. All parties have settled.
…
At its website as of Friday, the FDA still is not recommending it for COVID and says large doses are dangerous and that prescriptions should be filled by a pharmacy and taken exactly as prescribed.
The FDA declined to respond to Kennedy’s assertion, though it reiterated that it “has not changed its position that currently available clinical trial data do not demonstrate that ivermectin is effective against COVID-19. The agency has not authorized or approved ivermectin for use in preventing or treating COVID-19.”
I honestly don’t know what difference this’ll make. 🤷🏼♀️
Medicare to cover obesity drugs, but not for weight loss
Medicare to cover obesity drugs, but not for weight loss
“CMS has issued guidance to Medicare Part D plans stating that anti-obesity medications (AOMs) that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use,” the spokesperson added, specifying that drugs that are FDA-approved for only weight loss do not fall under this consideration.
Wegovy, Rybelsus, and Ozempic, are the different brand names for Semaglutide. They have a black box warning for Medullary thyroid cancer.* 🤦🏼♀️
Related:
Ms. Cat’s Chronicles 
You must be logged in to post a comment.